A study out of London found the possibility to predict the risk of developing the deliberating disease years before a clinical diagnosis is made.

Scientists reveal how an intranasally delivered oxytocin derivative could be used to treat Alzheimer's disease. Alzheimer's disease (AD), characterized by an accumulation of ß-amyloid protein (Aß) in brain tissue, is a leading cause of dementia. Researchers at Tokyo University of Science have previ